FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Klaas Hoekman

Research Profile

Procedures

Antineoplastic Combined Chemotherapy Protocols

Disorders

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Hester van Cruijsen; Karin Weijers; Cynthia Fehres; Giuseppe Giaccone; Klaas Hoekman; Jelle J Lindenberg; Sinéad M Lougheed; Dinja Oosterhoff; Rik J Scheper; Robert van Boerdonk; Tanja D de Gruijl
Glioblastoma-induced inhibition of Langerhans cell differentiation from CD34(+) precursors is mediated by IL-6 but unaffected by JAK2/STAT3 inhibition.
Hester van Cruijsen; Emile E Voest; Cornelis J A Punt; Klaas Hoekman; Petronella O Witteveen; Martijn R Meijerink; Thomas A Puchalski; Jane Robertson; Owain Saunders; Juliane M Jürgensmeier; Carla M L van Herpen; Giuseppe Giaccone
Phase I evaluation of cediranib, a selective VEGFR signalling inhibitor, in combination with gefitinib in patients with advanced tumours.
Marlies H G Langenberg; Carla M L van Herpen; Johann De Bono; Jan H M Schellens; Clemens Unger; Klaas Hoekman; Hubert E Blum; Walter Fiedler; Joachim Drevs; Florence Le Maulf; Anitra Fielding; Jane Robertson; Emile E Voest
Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: results from a phase II randomized, factorial, double-blind study of Cediranib in patients with advanced solid tumors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Klaas Hoekman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Hester van Cruijsen; Karin Weijers; Cynthia Fehres; Giuseppe Giaccone; Klaas Hoekman; Jelle J Lindenberg; Sinéad M Lougheed; Dinja Oosterhoff; Rik J Scheper; Robert van Boerdonk; Tanja D de Gruijl
Glioblastoma-induced inhibition of Langerhans cell differentiation from CD34(+) precursors is mediated by IL-6 but unaffected by JAK2/STAT3 inhibition.
Immunotherapy 2011;3(9):1051-61.
2010: Hester van Cruijsen; Emile E Voest; Cornelis J A Punt; Klaas Hoekman; Petronella O Witteveen; Martijn R Meijerink; Thomas A Puchalski; Jane Robertson; Owain Saunders; Juliane M Jürgensmeier; Carla M L van Herpen; Giuseppe Giaccone
Phase I evaluation of cediranib, a selective VEGFR signalling inhibitor, in combination with gefitinib in patients with advanced tumours.
European journal of cancer (Oxford, England : 1990) 2010;46(5):901-11.
2009: Marlies H G Langenberg; Carla M L van Herpen; Johann De Bono; Jan H M Schellens; Clemens Unger; Klaas Hoekman; Hubert E Blum; Walter Fiedler; Joachim Drevs; Florence Le Maulf; Anitra Fielding; Jane Robertson; Emile E Voest
Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: results from a phase II randomized, factorial, double-blind study of Cediranib in patients with advanced solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(36):6152-9.
2009: Hester van Cruijsen; Astrid van der Veldt; Klaas Hoekman
Tyrosine kinase inhibitors of VEGF receptors: clinical issues and remaining questions.
Frontiers in bioscience : a journal and virtual library 2009;14():2248-68.
2009: Laura Vroling; Astrid A M van der Veldt; Richard R de Haas; John B A G Haanen; Gerrit Jan Schuurhuis; Dirk J Kuik; Hester van Cruijsen; Hendrik Verheul; Alfons J M van den Eertwegh; Klaas Hoekman; Epie Boven; Victor W M van Hinsbergh; Henk J Broxterman
Increased numbers of small circulating endothelial cells in renal cell cancer patients treated with sunitinib.
Angiogenesis 2009;12(1):69-79.
2008: Hester van Cruijsen; Astrid A M van der Veldt; Laura Vroling; Dinja Oosterhoff; Henk J Broxterman; Rik J Scheper; Giuseppe Giaccone; John B A G Haanen; Alfons J M van den Eertwegh; Epie Boven; Klaas Hoekman; Tanja D de Gruijl
Sunitinib-induced myeloid lineage redistribution in renal cell cancer patients: CD1c+ dendritic cell frequency predicts progression-free survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(18):5884-92.
2007: Laura Vroling; Yuana Yuana; Gerrit J Schuurhuis; Victor W M van Hinsbergh; Chad Gundy; Richard de Haas; Hester van Cruijsen; Epie Boven; Klaas Hoekman; Henk J Broxterman
VEGFR2 expressing circulating (progenitor) cell populations in volunteers and cancer patients.
Thrombosis and haemostasis 2007;98(2):440-50.
2007: Martijn R Meijerink; Hester van Cruijsen; Klaas Hoekman; Matthijs Kater; Cors van Schaik; Jan-Hein T M van Waesberghe; Giuseppe Giaccone; Radu A Manoliu
The use of perfusion CT for the evaluation of therapy combining AZD2171 with gefitinib in cancer patients.
European radiology 2007;17(7):1700-13.
2007: Connie R Jimenez; Zineb El Filali; Jaco C Knol; Klaas Hoekman; Frank A E Kruyt; Giuseppe Giaccone; August B Smit; Ka Wan Li
Automated serum peptide profiling using novel magnetic C18 beads off-line coupled to MALDI-TOF-MS.
Proteomics. Clinical applications 2007;1(6):598-604.
2007: Hester van Cruijsen; Klaas Hoekman; A G M Stam; Alfons J M van den Eertwegh; Bart C Kuenen; Rik J Scheper; Giuseppe Giaccone; Tanja D de Gruijl
Defective differentiation of myeloid and plasmacytoid dendritic cells in advanced cancer patients is not normalized by tyrosine kinase inhibition of the vascular endothelial growth factor receptor.
Clinical & developmental immunology 2007;2007():17315.
2007: Jens van Wijngaarden; Ermond van Beek; Gerda van Rossum; Chris van Der Bent; Klaas Hoekman; Gabri van der Pluijm; Marjolein A van der Pol; Henk J Broxterman; Victor W M van Hinsbergh; Clemens W G M Löwik
Celecoxib enhances doxorubicin-induced cytotoxicity in MDA-MB231 cells by NF-kappaB-mediated increase of intracellular doxorubicin accumulation.
European journal of cancer (Oxford, England : 1990) 2007;43(2):433-42.
2006: Jeroen van Heijst; Hans W M Niessen; René J P Musters; Victor W M van Hinsbergh; Klaas Hoekman; Casper G Schalkwijk
Argpyrimidine-modified Heat shock protein 27 in human non-small cell lung cancer: a possible mechanism for evasion of apoptosis.
Cancer letters 2006;241(2):309-19.
2006: Anke Petra Jellema; Ben Slotman; Martin J Muller; René Leemans; Ludwig E Smeele; Klaas Hoekman; Neil K Aaronson; Johannes A Langendijk
Radiotherapy alone, versus radiotherapy with amifostine 3 times weekly, versus radiotherapy with amifostine 5 times weekly: A prospective randomized study in squamous cell head and neck cancer.
Cancer 2006;107(3):544-53.
2005: Hester van Cruijsen; Giuseppe Giaccone; Klaas Hoekman
Epidermal growth factor receptor and angiogenesis: Opportunities for combined anticancer strategies.
International journal of cancer. Journal international du cancer 2005;117(6):883-8.
2005: A H G Hansma; Henk J Broxterman; I van der Horst; Yuana Yuana; Epie Boven; Giuseppe Giaccone; HERBERT PINEDO; Klaas Hoekman
Recombinant human endostatin administered as a 28-day continuous intravenous infusion, followed by daily subcutaneous injections: a phase I and pharmacokinetic study in patients with advanced cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(10):1695-701.
2005: Bart C Kuenen; Giuseppe Giaccone; Rita Ruijter; astrid kok; Casper G Schalkwijk; Klaas Hoekman; HERBERT PINEDO
Dose-finding study of the multitargeted tyrosine kinase inhibitor SU6668 in patients with advanced malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(17):6240-6.
2005: Jeroen van Heijst; Hans W M Niessen; Klaas Hoekman; Casper G Schalkwijk
Advanced glycation end products in human cancer tissues: detection of Nepsilon-(carboxymethyl)lysine and argpyrimidine.
Annals of the New York Academy of Sciences 2005;1043():725-33.
2005: Victor W M van Hinsbergh; PIETER KOOLWIJK; Klaas Hoekman
The hemostatic system in angiogenesis.
EXS 2005;(94):247-66.
2004: Michiel de Bruin; Toni Van Capel; Kees Smid; Kasper van der Born; Masakazu Fukushima; Klaas Hoekman; HERBERT PINEDO; Godefridus J Peters
Role of platelet derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivity and potential role of deoxyribose-1-phosphate.
Nucleosides, nucleotides & nucleic acids 2004;23(8-9):1485-90.
2004: F P K Wu; Klaas Hoekman; C Sietses; B Mary E von Blomberg; Sybren Meijer; H J Bonjer; Miguel A Cuesta
Systemic and peritoneal angiogenic response after laparoscopic or conventional colon resection in cancer patients: a prospective, randomized trial.
Diseases of the colon and rectum 2004;47(10):1670-4.
2004: Michiel de Bruin; Toni Van Capel; Kees Smid; Masakazu Fukushima; Klaas Hoekman; HERBERT PINEDO; Godefridus J Peters
The effect of fluoropyrimidines with or without thymidine phosphorylase inhibitor on the expression of thymidine phosphorylase.
European journal of pharmacology 2004;491(2-3):93-9.
2004: A H G Hansma; Yvette van Hensbergen; Bart C Kuenen; Paulus van Diest; roeland hanemaaijer; Sybren Meijer; HERBERT PINEDO; Klaas Hoekman
A patient with a VEGF and endostatin producing gastrointestinal autonomic nerve tumour.
Journal of clinical pathology 2004;57(5):536-8.
2004: Yvette van Hensbergen; Henk J Broxterman; Sareena Rana; Paulus van Diest; Monique C A Duyndam; Klaas Hoekman; HERBERT PINEDO; Epie Boven
Reduced growth, increased vascular area, and reduced response to cisplatin in CD13-overexpressing human ovarian cancer xenografts.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(3):1180-91.
2004: F P K Wu; Johan R Westphal; Klaas Hoekman; Anneke K Mels; Markwin G Statius Muller; Robert W de Waal; Robert H J Beelen; Paul A M van Leeuwen; Sybren Meijer; Miguel A Cuesta
The effects of surgery, with or without rhGM-CSF, on the angiogenic profile of patients treated for colorectal carcinoma.
Cytokine 2004;25(2):68-72.
2003: F P K Wu; Petra G Boelens; Paul A M van Leeuwen; Klaas Hoekman; A H G Hansma; Marinus J Wiezer; Catharina Meijer; Sybren Meijer; michel scotté; Miguel A Cuesta
Effects of major liver resection, with or without recombinant bactericidal/permeability-increasing protein (rBPI21), on the angiogenic profile of patients with metastatic colorectal carcinoma.
Journal of surgical oncology 2003;84(3):137-42.
2003: Henk J Broxterman; Jan Lankelma; Klaas Hoekman
Resistance to cytotoxic and anti-angiogenic anticancer agents: similarities and differences.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2003;6(3):111-27.
2003: C C P Verstappen; Tjeerd J Postma; Klaas Hoekman; Jan J Heimans
Peripheral neuropathy due to therapy with paclitaxel, gemcitabine, and cisplatin in patients with advanced ovarian cancer.
Journal of neuro-oncology 2003;63(2):201-5.
2003: Bart C Kuenen; M Levi; J C M Meijers; Victor W M van Hinsbergh; Johannes Berkhof; A K Kakkar; Klaas Hoekman; HERBERT PINEDO
Potential role of platelets in endothelial damage observed during treatment with cisplatin, gemcitabine, and the angiogenesis inhibitor SU5416.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(11):2192-8.
2003: Bart C Kuenen; Josep Tabernero; Jose Baselga; Franco Cavalli; Elisabeth Pfanner; Pier Franco Conte; Siegfried Seeber; Srinivasan Madhusudan; Gael Deplanque; Holgen Huisman; Paul Scigalla; Klaas Hoekman; Adrian L Harris
Efficacy and toxicity of the angiogenesis inhibitor SU5416 as a single agent in patients with advanced renal cell carcinoma, melanoma, and soft tissue sarcoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(5):1648-55.
2003: Michiel de Bruin; Toni Van Capel; Kasper van der Born; Frank A E Kruyt; Masakazu Fukushima; Klaas Hoekman; HERBERT PINEDO; Godefridus J Peters
Role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivity.
British journal of cancer 2003;88(6):957-64.
2003: Michiel de Bruin; Kees Smid; Adrie C Laan; Paul Noordhuis; Masakazu Fukushima; Klaas Hoekman; HERBERT PINEDO; Godefridus J Peters
Rapid disappearance of deoxyribose-1-phosphate in platelet derived endothelial cell growth factor/thymidine phosphorylase overexpressing cells.
Biochemical and biophysical research communications 2003;301(3):675-9.
2003: F P K Wu; Klaas Hoekman; Sybren Meijer; Miguel A Cuesta
VEGF and endostatin levels in wound fluid and plasma after breast surgery.
Angiogenesis 2003;6(4):255-7.
2003: C C P Verstappen; Jan J Heimans; Klaas Hoekman; Tjeerd J Postma
Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management.
Drugs 2003;63(15):1549-63.
2002: Yvette van Hensbergen; Henk J Broxterman; roeland hanemaaijer; Anita S Jorna; Natascha A van Lent; Hendrik Verheul; HERBERT PINEDO; Klaas Hoekman
Soluble aminopeptidase N/CD13 in malignant and nonmalignant effusions and intratumoral fluid.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(12):3747-54.
2002: Jaap van Doorn; Cok M Hoogerbrugge; Johanna G Koster; Ruud J Bloemen; Klaas Hoekman; Aart H Mudde; Sylvia C van Buul-Offers
Antibodies directed against the E region of pro-insulin-like growth factor-II used to evaluate non-islet cell tumor-induced hypoglycemia.
Clinical chemistry 2002;48(10):1739-50.
2002: Bart C Kuenen; M Levi; J C M Meijers; A K Kakkar; Victor W M van Hinsbergh; P J Kostense; HERBERT PINEDO; Klaas Hoekman
Analysis of coagulation cascade and endothelial cell activation during inhibition of vascular endothelial growth factor/vascular endothelial growth factor receptor pathway in cancer patients.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(9):1500-5.
2002: Bart C Kuenen; Lee Rosen; Egbert F Smit; Mandy R N Parson; Marcel Levi; Rita Ruijter; Holger Huisman; Marc A Kedde; Paul Noordhuis; Wim J F van der Vijgh; Godefridus J Peters; Gillian F Cropp; Paul Scigalla; Klaas Hoekman; HERBERT PINEDO; Giuseppe Giaccone
Dose-finding and pharmacokinetic study of cisplatin, gemcitabine, and SU5416 in patients with solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(6):1657-67.
2002: Yvette van Hensbergen; Henk J Broxterman; Yvonne W Elderkamp; Jan Lankelma; Judith C C Beers; Marc Heijn; Epie Boven; Klaas Hoekman; HERBERT PINEDO
A doxorubicin-CNGRC-peptide conjugate with prodrug properties.
Biochemical pharmacology 2002;63(5):897-908.
2001: Jan Van den Brande; VR Nannan Panday; Klaas Hoekman; H Rosing; R V Huijskes; R H Verheijen; Jos H Beijnen; Jan B Vermorken
Pharmacologic study of paclitaxel administered with or without the cytoprotective agent amifostine, and given as a single agent or in combination with epirubicin and cisplatin in patients with advanced solid tumors.
American journal of clinical oncology 2001;24(4):401-3.
2000: Hendrik Verheul; Anita S Jorna; Klaas Hoekman; Henk J Broxterman; M F Gebbink; HERBERT PINEDO
Vascular endothelial growth factor-stimulated endothelial cells promote adhesion and activation of platelets.
Blood 2000;96(13):4216-21.
2000: B van Triest; HERBERT PINEDO; J L G Blaauwgeers; Paulus van Diest; PS Schoenmakers; Daphne Voorn; Kees Smid; Klaas Hoekman; H F Hoitsma; Godefridus J Peters
Prognostic role of thymidylate synthase, thymidine phosphorylase/platelet-derived endothelial cell growth factor, and proliferation markers in colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(3):1063-72.
2000: J B Bom; Hendrik Verheul; Klaas Hoekman; HERBERT PINEDO
[Coagulation disorders in cancer patients: possible opportunity for therapy].
Nederlands tijdschrift voor geneeskunde 2000;144(6):258-63.
2000: C M L van Herpen; Rob L Jansen; Wim H J Kruit; Klaas Hoekman; Gerard Groenewegen; S Osanto; P H M De Mulder
Immunochemotherapy with interleukin-2, interferon-alpha and 5-fluorouracil for progressive metastatic renal cell carcinoma: a multicenter phase II study. Dutch Immunotherapy Working Party.
British journal of cancer 2000;82(4):772-6.
2000: Godefridus J Peters; Michiel de Bruin; Masakazu Fukushima; B van Triest; Klaas Hoekman; HERBERT PINEDO; SP Ackland
Thymidine phosphorylase in angiogenesis and drug resistance. Homology with platelet-derived endothelial cell growth factor.
Advances in experimental medicine and biology 2000;486():291-4.
2000: Hendrik Verheul; Klaas Hoekman; Anita S Jorna; Egbert F Smit; HERBERT PINEDO
Targeting vascular endothelial growth factor blockade: ascites and pleural effusion formation.
The oncologist 2000;5 Suppl 1():45-50.
2000: Hendrik Verheul; Klaas Hoekman; Florea Lupu; Henk J Broxterman; Paul Van Der Valk; A K Kakkar; HERBERT PINEDO
Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(1):166-71.
1999: Klaas Hoekman; Jaap van Doorn; T Gloudemans; J A Maassen; A G Schuller; HERBERT PINEDO
Hypoglycaemia associated with the production of insulin-like growth factor II and insulin-like growth factor binding protein 6 by a haemangiopericytoma.
Clinical endocrinology 1999;51(2):247-53.
1999: Hendrik Verheul; J B Bom; Klaas Hoekman; HERBERT PINEDO
[Inhibition of tumor angiogenesis as a cancer treatment].
Nederlands tijdschrift voor geneeskunde 1999;143(30):1549-55.
1999: Jan Lankelma; Henk Dekker; F R Luque; S Luykx; Klaas Hoekman; P van der Valk; Paulus van Diest; HERBERT PINEDO
Doxorubicin gradients in human breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(7):1703-7.
1999: Klaas Hoekman; Wim J F van der Vijgh; J B Vermorken
Clinical and preclinical modulation of chemotherapy-induced toxicity in patients with cancer.
Drugs 1999;57(2):133-55.
1999: Tjeerd J Postma; Klaas Hoekman; J M G H van Riel; Jan J Heimans; Jan B Vermorken
Peripheral neuropathy due to biweekly paclitaxel, epirubicin and cisplatin in patients with advanced ovarian cancer.
Journal of neuro-oncology 1999;45(3):241-6.
1999: Aafke H Honkoop; Sylvia A Luykx-de Bakker; Klaas Hoekman; S Meyer; O W Meyer; Cees J van Groeningen; Paulus van Diest; Epie Boven; ELSKEN VAN DER WALL; Giuseppe Giaccone; John Wagstaff; HERBERT PINEDO
Prolonged neoadjuvant chemotherapy with GM-CSF in locally advanced breast cancer.
The oncologist 1999;4(2):106-11.
1998: Aafke H Honkoop; Paulus van Diest; JS De Jong; SC Linn; Giuseppe Giaccone; Klaas Hoekman; John Wagstaff; HERBERT PINEDO
Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer.
British journal of cancer 1998;77(4):621-6.
1997: Hendrik Verheul; Klaas Hoekman; Sylvia A Luykx-de Bakker; CA Eekman; C C Folman; Henk J Broxterman; HERBERT PINEDO
Platelet: transporter of vascular endothelial growth factor.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(12 Pt 1):2187-90.
1997: R E van Rijswijk; Klaas Hoekman; C W Burger; René H M Verheijen; Jan B Vermorken
Experience with intraperitoneal cisplatin and etoposide and i.v. sodium thiosulphate protection in ovarian cancer patients with either pathologically complete response or minimal residual disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(12):1235-41.
1997: Aafke H Honkoop; ELSKEN VAN DER WALL; Nicole Feller; Gerrit J Schuurhuis; Wim J F van der Vijgh; Epie Boven; Cees J van Groeningen; Giuseppe Giaccone; Klaas Hoekman; Jan B Vermorken; John Wagstaff; HERBERT PINEDO
Multiple cycles of high-dose doxorubicin and cyclophosphamide with G-CSF mobilized peripheral blood progenitor cell support in patients with metastatic breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(10):957-62.
1997: SC Linn; HERBERT PINEDO; J van Ark-Otte; P van der Valk; Klaas Hoekman; Aafke H Honkoop; Jan B Vermorken; Giuseppe Giaccone
Expression of drug resistance proteins in breast cancer, in relation to chemotherapy.
International journal of cancer. Journal international du cancer 1997;71(5):787-95.
1997: Nicole Feller; Klaas Hoekman; C M Kuiper; SC Linn; Hendrik Verheul; B G Wolthers; C Popp-Snijders; HERBERT PINEDO
A patient with adrenocortical carcinoma: characterization of its biological activity and drug resistance profile.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(3):389-94.
1997: Aafke H Honkoop; HERBERT PINEDO; JS De Jong; Hendrik Verheul; SC Linn; Klaas Hoekman; John Wagstaff; Paulus van Diest
Effects of chemotherapy on pathologic and biologic characteristics of locally advanced breast cancer.
American journal of clinical pathology 1997;107(2):211-8.
1997: Clasina L Van der Wilt; Cees J van Groeningen; HERBERT PINEDO; Kees Smid; Klaas Hoekman; Sybren Meijer; Godefridus J Peters
5-fluorouracil/leucovorin-induced inhibition of thymidylate synthase in normal tissues of mouse and man.
Journal of cancer research and clinical oncology 1997;123(11-12):595-601.
1997: Henk J Broxterman; Gerrit J Schuurhuis; Jan Lankelma; Jan W Oberink; CA Eekman; A M E Claessen; Klaas Hoekman; M Poot; HERBERT PINEDO
Highly sensitive and specific detection of P-glycoprotein function for haematological and solid tumour cells using a novel nucleic acid stain.
British journal of cancer 1997;76(8):1029-34.
1996: Aafke H Honkoop; Klaas Hoekman; John Wagstaff; Cees J van Groeningen; Jan B Vermorken; Epie Boven; HERBERT PINEDO
Continuous infusion or subcutaneous injection of granulocyte-macrophage colony-stimulating factor: increased efficacy and reduced toxicity when given subcutaneously.
British journal of cancer 1996;74(7):1132-6.
1996: SC Linn; Aafke H Honkoop; Klaas Hoekman; Paul Van Der Valk; HERBERT PINEDO; Giuseppe Giaccone
p53 and P-glycoprotein are often co-expressed and are associated with poor prognosis in breast cancer.
British journal of cancer 1996;74(1):63-8.
1996: Aafke H Honkoop; Klaas Hoekman; John Wagstaff; Epie Boven; Cees J van Groeningen; Giuseppe Giaccone; Jan B Vermorken; HERBERT PINEDO
Dose-intensive chemotherapy with doxorubicin, cyclophosphamide and GM-CSF fails to improve survival of metastatic breast cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(1):35-9.
1994: Klaas Hoekman; Jaap van Doorn; T Gloudemans; O S Hoekstra; J A Maassen; Jan B Vermorken; John Wagstaff; HERBERT PINEDO
Tumour-induced hypoglycaemia: a case report.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(3):277-81.